Generate Biomedicines Inc (GENB) Price Prediction & Forecast

$12.410

-0.369 (-2.97%)At close

Price Predictions

1-Day Price Prediction

+0.26%

1-Week Prediction

+0.28%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

GENB Prediction & Forecast by Similar Chart Analysis

Alphio's GENB stock price prediction model matches the current Generate Biomedicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.44 (+0.26%). The 1-week path is $12.44 (+0.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Generate Biomedicines Inc Stock?

Generate Biomedicines, Inc. is currently not a good buy due to its declining financial performance and significant net losses. The stock is trading at $12.41 with a 1-year change of -22.44%. The RSI is at 37.038, indicating it is nearing oversold territory, but the forward P/E is at 0, reflecting uncertainty in future earnings. The main risk is the net loss of $67.3 million reported for Q2 2026, which raises concerns about liquidity and operational sustainability.